Quality Control Flaws Cited at Boston Scientific
From Bloomberg News
Boston Scientific Corp., the largest maker of cardiac stents for the U.S. market, said it received a warning letter from regulators citing flaws in quality management at six facilities.
The Food and Drug Administration said it wouldn’t approve some life-sustaining products made at the cited plants until the problems were corrected, the Natick, Mass.-based company said. The FDA also said it wouldn’t issue export licenses for the affected products.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
